(Q33289952)

25 July 2017

1 reference

title

Lower urinary tract symptoms and erectile dysfunction; links for diagnosis, management and treatment (English)

1 reference

25 July 2017

1 reference

Ponholzer A

1

1 reference

25 July 2017

Madersbacher S

series ordinal

2

1 reference

25 July 2017

language of work or name

1 reference

5 July 2007

1 reference

International Journal of Impotence Research

25 July 2017

published in

1 reference

25 July 2017

volume

19

1 reference

25 July 2017

issue

6

1 reference

25 July 2017

page(s)

544-550

1 reference

EAU Guidelines on erectile dysfunction: an update

25 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901578

EAU 2004 guidelines on assessment, therapy and follow-up of men with lower urinary tract symptoms suggestive of benign prostatic obstruction (BPH guidelines).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901578

Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging male (MSAM-7).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901578

Sexual dysfunction in 1,274 European men suffering from lower urinary tract symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901578

The association between lower urinary tract symptoms and erectile dysfunction in four centres: the UrEpik study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901578

Lower urinary tract symptoms (LUTS) and sexual function in both sexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901578

Association between lower urinary tract symptoms and erectile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901578

Prospective study of men with clinical benign prostatic hyperplasia treated with alfuzosin by general practitioners: 1-year results.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901578

Erectile dysfunction and lower urinary tract symptoms secondary to BPH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901578

Sexual dysfunction and lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901578

The relationship between erectile dysfunction and lower urinary tract symptoms: epidemiological, clinical, and basic science evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901578

Sildenafil influences lower urinary tract symptoms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901578

The association between vascular risk factors and lower urinary tract symptoms in both sexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901578

Benign prostatic hyperplasia (the aging prostate).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901578

Is the metabolic syndrome an independent risk factor for erectile dysfunction?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901578

Assessment of the impact of sildenafil citrate on lower urinary tract symptoms in men with erectile dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901578

Sildenafil citrate improves erectile function and urinary symptoms in men with erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia: a randomized, double-blind trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901578

Impact of medical treatments for benign prostatic hyperplasia on sexual function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901578

Combination of phosphodiesterase-5 inhibitors and alpha-blockers in patients with benign prostatic hyperplasia: treatments of lower urinary tract symptoms, erectile dysfunction, or both?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901578

Alfuzosin 10 mg once daily improves sexual function in men with lower urinary tract symptoms and concomitant sexual dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901578

Efficacy and safety of a dual inhibitor of 5-alpha-reductase types 1 and 2 (dutasteride) in men with benign prostatic hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901578

The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901578

Simultaneous administration of vardenafil and tamsulosin does not induce clinically significant hypotension in patients with benign prostatic hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901578

A comparison of transurethral surgery with watchful waiting for moderate symptoms of benign prostatic hyperplasia. The Veterans Affairs Cooperative Study Group on Transurethral Resection of the Prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901578

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901578

7 January 2021

Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901578

7 January 2021

Lower urinary tract symptoms and erectile dysfunction: co-morbidity or typical "Aging Male" symptoms? Results of the "Cologne Male Survey"

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901578

7 January 2021

Prevalence of erectile dysfunction and associated factors among men without concomitant diseases: a population study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901578

7 January 2021

Association of lower urinary tract symptoms with erectile dysfunction in Japanese men

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901578

7 January 2021

EFFECT OF LOWER URINARY TRACT SYMPTOMS ON THE INCIDENCE OF ERECTILE DYSFUNCTION

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901578

7 January 2021

Obstruction-induced changes in urinary bladder smooth muscle contractility: a role for Rho kinase

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901578

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901578

7 January 2021

Growth of the rat prostate gland is facilitated by the autonomic nervous system

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901578

7 January 2021

AUA guideline on management of benign prostatic hyperplasia (2003). Chapter 1: Diagnosis and treatment recommendations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901578

7 January 2021

Hemodynamic interaction study between the alpha1-blocker alfuzosin and the phosphodiesterase-5 inhibitor tadalafil in middle-aged healthy male subjects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901578

7 January 2021

Identifiers

DOI

10.1038/SJ.IJIR.3901578

1 reference

Dimensions Publication ID

25 July 2017

1006700120

0 references

1 reference